Catalyst Wire Dossier Catalyst Wire Dossier

lenalidomide and dexamethasone with or without pembrolizumab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for lenalidomide and dexamethasone with or without pembrolizumab, covering 2019-09-17 to 2019-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185) [Phase 3]

See pricing